Hence, given the emerging importance of the NLRP3 inflammasome in DN, as evidenced by the above studies, targeting the NLRP3 inflammasome may be a potential therapeutic strategy to effectively treat DN (Sakai and Wada, 2015). Here, NLRP3 is linked to liver dysplastic nodule.